April 21, 2018 6:10 AM ET


Company Overview of Cita NeuroPharmaceuticals Inc.

Company Overview

As of December 14, 2005, Cita NeuroPharmaceuticals Inc. was acquired by Vernalis plc. Cita NeuroPharmaceuticals Inc. operates as a neuropharmaceutical company, develops and commercializes small molecule drug candidates for neurological diseases and disorders. The company focuses on developing drugs for the treatment of disease states related to the central nervous system (CNS) and the cardiovascular system. Its products include CNP1512 drug for the treatment of Parkinson's disease; CNP3381 for the treatment of neuropathic pain; and CNP1061 for the treatment of Alzheimer's disease. The company was formerly known as GB Therapeutics, Ltd. and changed its name to Cita NeuroPharmaceuticals Inc. i...

2480 Dunwin Drive

Mississauga, ON L5L 1J9


Founded in 1997

9 Employees





Key Executives for Cita NeuroPharmaceuticals Inc.

Cita NeuroPharmaceuticals Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
1113131 B.C. Ltd. Americas
1127466 B.C. Ltd. Americas
1600978 Ontario Inc. Americas
48North Cannabis Corporation Americas
4everPets Ltd. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cita NeuroPharmaceuticals Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.